Two-year clinical progression in focal and diffuse subtypes of Parkinson’s disease

Heterogeneity in Parkinson’s disease (PD) presents a barrier to understanding disease mechanisms and developing new treatments. This challenge may be partially overcome by stratifying patients into clinically meaningful subtypes. A recent subtyping scheme classifies de novo PD patients into three su...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Martin E., van Lier, Nina M., Kessels, Roy P. C., Bloem, Bastiaan R., Helmich, Rick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937525/
https://www.ncbi.nlm.nih.gov/pubmed/36806285
http://dx.doi.org/10.1038/s41531-023-00466-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937525/
https://www.ncbi.nlm.nih.gov/pubmed/36806285
http://dx.doi.org/10.1038/s41531-023-00466-4

Ejemplares similares